News Articles http://www.bioresearchonline.com/ Thu, 02 Jul 2009 10:38:00 GMT R&D Logic, preferred provider of web based business management software specific to the Life Sciences Industry, today announced five new additions to their Life Sciences Customer Community. http://www.bioresearchonline.com/article.mvc/RD-Logics-Unique-Products-And-Services-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Jul 2009 10:38:00 GMT Critical Outcome Technologies Inc. (TSX VENTURE:COT), announced positive results today from combination agent animal experiments carried out at a prominent American cancer research facility. http://www.bioresearchonline.com/article.mvc/Intravenous-COTI-2-In-Combination-With-0001?atc~c=771+s=773+r=001+l=a Thu, 02 Jul 2009 10:22:00 GMT Stemedica Cell Technologies, Inc., ("Stemedica"),a leader in the manufacturing and development of clinical grade allogeneic adult stem cell technology, has discovered a significant breakthrough in the use of human stem cells and stem cell factors for the potential treatment of degenerations of the retina and retinal pigmented epithelium. http://www.bioresearchonline.com/article.mvc/Stemedica-Discovers-Significant-Breakthrough-0001?atc~c=771+s=773+r=001+l=a Wed, 01 Jul 2009 09:52:00 GMT Hamilton Robotics introduces MICROLAB® NIMBUS NVS (NIMBUS Vacuum System), an integrated platform for automated vacuum-based separations. NIMBUS NVS integrates liquid handling workstation capabilities with a vacuum manifold, pump and collection device for solid-phase extraction (SPE) of analytes from complex biological mixtures in 96-well plate format. http://www.bioresearchonline.com/article.mvc/New-NIMBUS-System-Automates-Vacuum-Based-SPE-0001?atc~c=771+s=773+r=001+l=a Wed, 01 Jul 2009 09:04:00 GMT Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, announced a research collaboration agreement with Synageva BioPharma Corporation to express and develop therapeutic monoclonal antibodies for the potential treatment of various forms of cancer and infectious disease. http://www.bioresearchonline.com/article.mvc/Morphotek-Inc-Announces-A-Research-0001?atc~c=771+s=773+r=001+l=a Wed, 01 Jul 2009 05:12:00 GMT Rubicon Genomics, Inc., a developer of pre-amplification products that enable optimal performance of the most advanced genetic analysis tools, announced today the release of its PicoPlex Single Cell Whole Genome Amplification (WGA) kit-a more rapid, accurate and reproducible method for amplifying single genomes than current technologies. http://www.bioresearchonline.com/article.mvc/Rubicon-Genomics-Introduces-PicoPlex-Single-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 15:32:00 GMT BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that the United States Environmental Protection Agency (EPA) will utilize BioSeek's BioMAP Systems technology to profile the biological effects of compounds in a second phase of the agency's ToxCast program. http://www.bioresearchonline.com/article.mvc/BioSeek-And-EPA-Expand-ToxCast-Contract-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 13:01:00 GMT POZEN Inc., today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole. http://www.bioresearchonline.com/article.mvc/POZEN-Submits-New-Drug-Application-For-VIMOVO-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 12:02:00 GMT GE Healthcare, a unit of General Electric Company, and Geron Corporation today announced that they have entered into a global exclusive license and alliance agreement to develop and commercialize cellular assay products derived from human embryonic stem cells (hESCs) for use in drug discovery, development and toxicity screening. http://www.bioresearchonline.com/article.mvc/GE-Healthcare-And-Geron-Announce-Exclusive-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 11:30:00 GMT Global market for Autoimmune Disease Therapeutics is projected to reach US$49.8B in 2015. Biologics emerged as the leading therapeutic option in the treatment of autoimmune diseases, owing to their superior efficacy compared to conventional small molecule drugs. http://www.bioresearchonline.com/article.mvc/Global-Autoimmune-Disease-Therapeutics-Market-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 10:11:00 GMT Florida Biologix is a unique contract manufacturing organization capable of helping companies get products through proof of concept and phase I studies quickly and at reasonable cost. http://www.bioresearchonline.com/article.mvc/Early-Stage-Process-Development-Florida-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 08:47:00 GMT Sales of Malvern Instruments' Mastersizer systems have exceeded the 10,000 instruments mark, a major milestone in the company's history. Now used by more than 90% of the world's leading chemical and pharmaceutical companies, Mastersizer laser diffraction particle size analyzers have become the systems of choice in companies of all sizes across many different industries. http://www.bioresearchonline.com/article.mvc/Malvern-Mastersizer-Sales-Top-The-10000-Mark-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 08:15:00 GMT Biological drugs are the big winners in the market for autoimmune disorders. http://www.bioresearchonline.com/article.mvc/Biologics-Dominate-The-Autoimmune-Market-But-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 05:59:00 GMT Ambient ID, Inc. today unveiled the company's LabTrack solution -- a comprehensive business information management system proven in diagnostic laboratories and hospitals throughout North America to significantly improve operational efficiency and reduce test costs. http://www.bioresearchonline.com/article.mvc/Ambient-ID-Unveils-LabTrack-Diagnostic-0001?atc~c=771+s=773+r=001+l=a Tue, 30 Jun 2009 05:44:00 GMT Recommendations for how the HHS Office of the Secretary will spend $400M in funds for patient-centered research, also known as comparative effectiveness research, were released today by Federal Coordinating Council for Comparative Effectiveness Research (CER). http://www.bioresearchonline.com/article.mvc/Patient-Centered-Research-Report-Sent-To-0001?atc~c=771+s=773+r=001+l=a Mon, 29 Jun 2009 17:05:00 GMT Synexus' Chris Hannigan will present his vision for how the clinical trials industry must respond to the changing landscape faced by the pharmaceutical sector and embrace innovative practices to improve the speed of clinical trials, rein in costs and increase the statistical power of the results particularly in Phase II. http://www.bioresearchonline.com/article.mvc/Meeting-The-Clinical-Trials-Challenge-How-0001?atc~c=771+s=773+r=001+l=a Mon, 29 Jun 2009 12:26:00 GMT Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence (EMI) software solutions, announced recently that its annual user conference,Aegis Discover 2009, will be held Oct. 5-8 at the St. Julien Hotel in Boulder, Colo. http://www.bioresearchonline.com/article.mvc/Aegis-Analyticals-Discover-2009-Conference-0001?atc~c=771+s=773+r=001+l=a Mon, 29 Jun 2009 12:00:00 GMT Rexahn Pharmaceuticals, Inc., recently announced that it has signed an exclusive collaboration and option for license agreement with a top 20 global pharmaceutical company (the "Partner Co.") for the development of RX-3117. http://www.bioresearchonline.com/article.mvc/Rexahn-Pharmaceuticals-Signs-Development-And-0001?atc~c=771+s=773+r=001+l=a Mon, 29 Jun 2009 12:00:00 GMT ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today the issuance of a Japanese patent relating to the company's monoclonal antibody therapeutics. http://www.bioresearchonline.com/article.mvc/ImmunoCellular-Therapeutics-Announces-0001?atc~c=771+s=773+r=001+l=a Mon, 29 Jun 2009 12:00:00 GMT Today, at the 17th international conference on Intelligent Systems for Molecular Biology (ISMB) and 8th European Conference on Computational Biology (ECCB) in Stockholm, Sweden, CLC bio has revealed their first turnkey biocomputing solution for analyzing and visualizing Next Generation Sequencing data, called CLC Genomics Machine. http://www.bioresearchonline.com/article.mvc/CLC-Bio-Reveals-Biocomputing-Solution-At-ISMB-0001?atc~c=771+s=773+r=001+l=a Mon, 29 Jun 2009 07:56:00 GMT